ROCHESTER, N.Y., January 27, 2010
NaturalNano, Inc. (Pink Sheets: NNAN) (Frankfurt: N3N) announced today Fiabila S.A., a world leader in private label nail polish manufacture has committed to continue its use of NaturalNano’s environmentally friendly Halloysite Natural Tube (HNT) technology in their nail polish products.
Acting CEO & President James Wemett said” NNAN is very pleased with the technical and commercial success shown to date in the Fiabila nail polish product. We are very pleased with our association with Fiabila one of the world’s leading private manufacturer of nail enamels. The Fiabila manufactured products with HNT are available at most leading stores including Walmart, CVS and Walgreens.”
James Wemett continued, "This relationship with Fiabila represents a long term revenue opportunity for NaturalNano that utilizes our HNT™, which provides increased durability and performance to their nail polish products.” NaturalNano has a three year exclusive supply agreement and license with Fiabila for nail polish and nail-care products.
Pierre Miasnik, President of Fiabila commented, “NaturalNano’s technology has enabled us to continue to have an edge in the market place and to use Natural ingredients in our products for our customers.”
About NaturalNano, Inc.
NaturalNano, Inc. (Pink Sheets: NNAN) (Frankfurt: N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including their proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and licenses 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite. www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.